DiaMedica Therapeutics Inc. (DMAC) Revenue (2018)
DiaMedica Therapeutics (DMAC) has 1 years of Revenue data on record, last reported at $500000.0 in Q3 2018.
- For Q3 2018, Revenue changed N/A year-over-year to $500000.0; the TTM value through Jun 2019 reached $500000.0, changed N/A, while the annual FY2024 figure was -$34000.0, 54.55% down from the prior year.
- Revenue reached $500000.0 in Q3 2018 per DMAC's latest filing.
- Across five years, Revenue topped out at $500000.0 in Q3 2018 and bottomed at $500000.0 in Q3 2018.